{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T03:19:52Z","timestamp":1782962392260,"version":"3.54.5"},"reference-count":135,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Johann Wolfgang Goethe-Universit\u00e4t, Frankfurt am Main"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s15010-025-02718-2","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T14:51:20Z","timestamp":1769179880000},"page":"1041-1062","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A review on antibiotic and non-antibiotic decolonization strategies of multidrug-resistant bacteria in the gastrointestinal tract"],"prefix":"10.1007","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3739-9601","authenticated-orcid":false,"given":"Tobias","family":"Weirauch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dafna","family":"Yahav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itay","family":"Zahavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"W\u00fcrstle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J. G. T.","family":"Vehreschild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"key":"2718_CR1","unstructured":"O\u2019Neill J. Tackling drug-resistant infections globally: final report and recommendations. Government of the United Kingdom. 2016."},{"key":"2718_CR2","unstructured":"World Health Organization. Global antimicrobial resistance and use surveillance system (GLASS) report 2022. Geneva: WHO; 2022. Licence: CC BY-NC-SA 3.0 IGO."},{"key":"2718_CR3","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"Antimicrobial Resistance Collaborators","year":"2022","unstructured":"Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399:629\u201355. https:\/\/doi.org\/10.1016\/S0140-6736(21)02724-0.","journal-title":"Lancet"},{"key":"2718_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.pmbts.2022.07.009","volume":"192","author":"D Paul","year":"2022","unstructured":"Paul D, Das B. Gut microbiome in the emergence of antibiotic-resistant bacterial pathogens. Prog Mol Biol Transl Sci. 2022;192:1\u201331. https:\/\/doi.org\/10.1016\/bs.pmbts.2022.07.009.","journal-title":"Prog Mol Biol Transl Sci"},{"key":"2718_CR5","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1006\/anae.1997.0102","volume":"3","author":"E Bezirtzoglou","year":"1997","unstructured":"Bezirtzoglou E. The intestinal microflora during the first weeks of life. Anaerobe. 1997;3:173\u20137. https:\/\/doi.org\/10.1006\/anae.1997.0102.","journal-title":"Anaerobe"},{"key":"2718_CR6","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41579-021-00534-7","volume":"19","author":"IL Brito","year":"2021","unstructured":"Brito IL. Examining horizontal gene transfer in microbial communities. Nat Rev Microbiol. 2021;19:442\u201353. https:\/\/doi.org\/10.1038\/s41579-021-00534-7.","journal-title":"Nat Rev Microbiol"},{"key":"2718_CR7","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3390\/microorganisms7090363","volume":"7","author":"JM Bello-L\u00f3pez","year":"2019","unstructured":"Bello-L\u00f3pez JM, Cabrero-Mart\u00ednez OA, Ib\u00e1\u00f1ez-Cervantes G, et al. Horizontal gene transfer and its association with antibiotic resistance in Aeromonas spp. Microorganisms. 2019;7:363. https:\/\/doi.org\/10.3390\/microorganisms7090363.","journal-title":"Microorganisms"},{"key":"2718_CR8","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s40168-023-01479-0","volume":"11","author":"JS Inda-D\u00edaz","year":"2023","unstructured":"Inda-D\u00edaz JS, Lund D, Parras-Molt\u00f3 M, et al. Latent antibiotic resistance genes in human, animal, and environmental microbiomes. Microbiome. 2023;11:44. https:\/\/doi.org\/10.1186\/s40168-023-01479-0.","journal-title":"Microbiome"},{"key":"2718_CR9","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S1473-3099(22)00811-8","volume":"23","author":"RPJ Willems","year":"2023","unstructured":"Willems RPJ, van Dijk K, Vehreschild MJGT, et al. Incidence of infection with multidrug-resistant gram-negative bacteria and vancomycin-resistant enterococci in carriers: a systematic review and meta-regression analysis. Lancet Infect Dis. 2023;23:719\u201331.","journal-title":"Lancet Infect Dis"},{"key":"2718_CR10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jinf.2021.11.007","volume":"84","author":"G Arzilli","year":"2022","unstructured":"Arzilli G, Scardina G, Casigliani V, et al. Screening for antimicrobial-resistant Gram-negative bacteria in hospitalized patients and risk of progression to infection: systematic review. J Infect. 2022;84:119\u201330.","journal-title":"J Infect"},{"key":"2718_CR11","doi-asserted-by":"publisher","first-page":"455","DOI":"10.37201\/req\/062.2022","volume":"35","author":"R Ferrer","year":"2022","unstructured":"Ferrer R, Soriano A, Cant\u00f3n R, et al. Risk factors for infection progression in colonised patients with carbapenem-resistant gram-negative bacteria: systematic review and expert consensus. Rev Esp Quimioter. 2022;35:455\u201367.","journal-title":"Rev Esp Quimioter"},{"key":"2718_CR12","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1007\/s00134-018-5268-8","volume":"44","author":"DE Freedberg","year":"2018","unstructured":"Freedberg DE, Zhou MJ, Cohen ME, et al. Pathogen colonization of the gastrointestinal microbiome at ICU admission and risk of death or infection. Intensive Care Med. 2018;44:1203\u201311.","journal-title":"Intensive Care Med"},{"key":"2718_CR13","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s13054-024-04999-9","volume":"28","author":"MR Heath","year":"2024","unstructured":"Heath MR, Fan W, Leu CS, et al. Gut colonization with multidrug resistant organisms in the ICU: systematic review and meta-analysis. Crit Care. 2024;28:211. https:\/\/doi.org\/10.1186\/s13054-024-04999-9.","journal-title":"Crit Care"},{"key":"2718_CR14","doi-asserted-by":"publisher","unstructured":"Alevizakos M, Gaitanidis A, Nasioudis D, et al. Colonization with vancomycin-resistant enterococci and bloodstream infection risk in malignancy: systematic review. Open Forum Infect Dis. 2016;4(1):ofw246. https:\/\/doi.org\/10.1093\/ofid\/ofw246.","DOI":"10.1093\/ofid\/ofw246"},{"key":"2718_CR15","doi-asserted-by":"publisher","first-page":"127249","DOI":"10.1016\/j.micres.2022.127249","volume":"266","author":"J Ma","year":"2023","unstructured":"Ma J, Song X, Li M, Yu Z, Cheng W, Yu Z, et al. Global spread of carbapenem-resistant Enterobacteriaceae: epidemiological features, resistance mechanisms, detection and therapy. Microbiol Res. 2023;266:127249.","journal-title":"Microbiol Res"},{"key":"2718_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2025.107668","author":"MM Walker","year":"2025","unstructured":"Walker MM, Roberts JA, Li Y, Sime FB. Global epidemiology of carbapenem-resistant Escherichia coli: systematic review and meta-analysis. Int J Antimicrob Agent. 2025. https:\/\/doi.org\/10.1016\/j.ijantimicag.2025.107668.","journal-title":"Int J Antimicrob Agent"},{"key":"2718_CR17","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13756-023-01278-0","volume":"12","author":"C Cimen","year":"2023","unstructured":"Cimen C, Berends MS, Bathoorn E, et al. Vancomycin-resistant enterococci in hospitals across the Netherlands and Germany: scoping review. Antimicrob Resist Infect Control. 2023;12:78.","journal-title":"Antimicrob Resist Infect Control"},{"key":"2718_CR18","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.cmi.2021.02.025","volume":"27","author":"BD Huttner","year":"2021","unstructured":"Huttner BD. Fighting fire with fire: oral antibiotics for suppression of MDR Enterobacterales colonization. Clin Microbiol Infect. 2021;27:821\u20132.","journal-title":"Clin Microbiol Infect"},{"key":"2718_CR19","doi-asserted-by":"publisher","first-page":"e13215","DOI":"10.1111\/tid.13215","volume":"22","author":"PJ Bhatt","year":"2020","unstructured":"Bhatt PJ, Ali M, Rana M, et al. Infections due to multidrug-resistant organisms after heart transplantation. Transpl Infect Dis. 2020;22:e13215. https:\/\/doi.org\/10.1111\/tid.13215.","journal-title":"Transpl Infect Dis"},{"issue":"Suppl 7","key":"2718_CR20","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/1469-0691.12687","volume":"20","author":"C Cervera","year":"2014","unstructured":"Cervera C, van Delden C, Gavalda J, et al. Multidrug-resistant bacteria in solid organ transplant recipients. Clin Microbiol Infect. 2014;20(Suppl 7):49\u201373.","journal-title":"Clin Microbiol Infect"},{"key":"2718_CR21","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1093\/jac\/dkw221","volume":"71","author":"H Bar-Yoseph","year":"2016","unstructured":"Bar-Yoseph H, Hussein K, Braun E, Paul M. Natural history and decolonization strategies for ESBL\/carbapenem-resistant Enterobacteriaceae carriage: systematic review and meta-analysis. J Antimicrob Chemother. 2016;71:2729\u201339.","journal-title":"J Antimicrob Chemother"},{"key":"2718_CR22","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1093\/jac\/dkw383","volume":"72","author":"S Isaac","year":"2017","unstructured":"Isaac S, Scher JU, Djukovic A, et al. Short and long-term effects of oral vancomycin on human intestinal microbiota. J Antimicrob Chemother. 2017;72:128\u201336.","journal-title":"J Antimicrob Chemother"},{"key":"2718_CR23","first-page":"21","volume":"4","author":"L Silvestri","year":"2012","unstructured":"Silvestri L, van Saene HKF. Selective decontamination of the digestive tract: update of the evidence. HSR Proc Intensive Care Cardiovasc Anesth. 2012;4:21\u20139.","journal-title":"HSR Proc Intensive Care Cardiovasc Anesth"},{"key":"2718_CR24","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1086\/322687","volume":"33","author":"MT Wong","year":"2001","unstructured":"Wong MT, Kauffman CA, Standiford HC, et al. Suppression of VRE by ramoplanin. Clin Infect Dis. 2001;33:1476\u201382.","journal-title":"Clin Infect Dis"},{"key":"2718_CR25","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1086\/321895","volume":"33","author":"KE Mondy","year":"2001","unstructured":"Mondy KE, Shannon W, Mundy LM. Zinc bacitracin for eradication of VRE. Clin Infect Dis. 2001;33:473\u20136.","journal-title":"Clin Infect Dis"},{"key":"2718_CR26","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1086\/520216","volume":"29","author":"MR Weinstein","year":"1999","unstructured":"Weinstein MR, Dedier H, Brunton J, et al. Oral bacitracin plus doxycycline fails to eradicate VRE colonization. Clin Infect Dis. 1999;29:361\u20136.","journal-title":"Clin Infect Dis"},{"key":"2718_CR27","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1093\/jac\/dkz124","volume":"74","author":"V Dimitriou","year":"2019","unstructured":"Dimitriou V, Biehl LM, Hamprecht A, et al. ESBL decolonization in hematology patients (CLEAR trial). J Antimicrob Chemother. 2019;74:2065\u201374.","journal-title":"J Antimicrob Chemother"},{"key":"2718_CR28","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1093\/jac\/dkt171","volume":"68","author":"B Huttner","year":"2013","unstructured":"Huttner B, Haustein T, Uckay I, et al. Decolonization of ESBL-E with colistin + neomycin: RCT. J Antimicrob Chemother. 2013;68:2375\u201382.","journal-title":"J Antimicrob Chemother"},{"key":"2718_CR29","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.cmi.2020.12.016","volume":"27","author":"MC Farinas","year":"2021","unstructured":"Farinas MC, Gonzalez-Rico C, Fernandez-Martinez M, et al. Oral colistin + neomycin in SOT recipients colonized with MDR Enterobacterales. Clin Microbiol Infect. 2021;27:856\u201363.","journal-title":"Clin Microbiol Infect"},{"key":"2718_CR30","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.jhin.2010.06.020","volume":"76","author":"F Brossier","year":"2010","unstructured":"Brossier F, Lefrancois S, Paute J, et al. Early decolonisation to control VRE outbreak. J Hosp Infect. 2010;76:368\u20139.","journal-title":"J Hosp Infect"},{"key":"2718_CR31","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.cmi.2018.12.009","volume":"25","author":"BD Huttner","year":"2019","unstructured":"Huttner BD, de Lastours V, Wassenberg M, et al. Oral antibiotics followed by FMT for MDR-E eradication: RCT. Clin Microbiol Infect. 2019;25:830\u20138.","journal-title":"Clin Microbiol Infect"},{"key":"2718_CR32","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1186\/1471-2334-14-514","volume":"14","author":"VC Cheng","year":"2014","unstructured":"Cheng VC, Chen JH, Tai JW, et al. Decolonization of VRE: case series and review. BMC Infect Dis. 2014;14:514.","journal-title":"BMC Infect Dis"},{"key":"2718_CR33","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.jiph.2023.01.009","volume":"16","author":"A Mascolo","year":"2023","unstructured":"Mascolo A, Carannante N, Mauro GD, et al. Decolonization of drug-resistant Enterobacteriaceae: scoping review. J Infect Public Health. 2023;16:376\u201383.","journal-title":"J Infect Public Health"},{"key":"2718_CR34","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1093\/clinids\/21.6.1520","volume":"21","author":"JK Chia","year":"1995","unstructured":"Chia JK, Nakata MM, Park SS, et al. Bacitracin therapy for VRE infection. Clin Infect Dis. 1995;21:1520.","journal-title":"Clin Infect Dis"},{"key":"2718_CR35","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1086\/501968","volume":"23","author":"R Hachem","year":"2002","unstructured":"Hachem R, Raad I. Failure of oral antimicrobials to eradicate VRE. Infect Control Hosp Epidemiol. 2002;23:43\u20134.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2718_CR36","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0732-8893(94)90074-4","volume":"18","author":"CA O'Donovan","year":"1994","unstructured":"O\u2019Donovan CA, Fan-Havard P, Tecson-Tumang FT, et al. Eradication of VRE with oral bacitracin. Diagn Microbiol Infect Dis. 1994;18:105\u20139.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2718_CR37","doi-asserted-by":"publisher","first-page":"e2018030","DOI":"10.4084\/mjhid.2018.030","volume":"10","author":"I Stoma","year":"2018","unstructured":"Stoma I, Karpov I, Iskrov I, et al. Decolonization of intestinal carriage of MDR\/XDR gram-negative bacteria with oral colistin in patients with hematological malignancies: results of a randomized controlled trial. Mediterr J Hematol Infect Dis. 2018;10:e2018030.","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"2718_CR38","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s13054-018-2170-2","volume":"22","author":"E De Jonge","year":"2018","unstructured":"De Jonge E, De Wilde RBP, Juffermans NP, et al. Carriage after discontinuation of SDD\/SOD. Crit Care. 2018;22:243.","journal-title":"Crit Care"},{"key":"2718_CR39","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s13054-018-2057-2","volume":"22","author":"C S\u00e1nchez-Ram\u00edrez","year":"2018","unstructured":"S\u00e1nchez-Ram\u00edrez C, H\u00edpola-Escalada S, Cabrera-Santana M, et al. Long-term SDD in ICU with high resistance prevalence. Crit Care. 2018;22:244.","journal-title":"Crit Care"},{"key":"2718_CR40","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.jhin.2020.08.007","volume":"106","author":"H Bar-Yoseph","year":"2020","unstructured":"Bar-Yoseph H, Lulu C, Shklar S, et al. SDD policy for CRE carriers: prospective study. J Hosp Infect. 2020;106:495\u20139.","journal-title":"J Hosp Infect"},{"key":"2718_CR41","doi-asserted-by":"publisher","first-page":"630826","DOI":"10.3389\/fmicb.2021.630826","volume":"12","author":"M Pellic\u00e9","year":"2021","unstructured":"Pellic\u00e9 M, Rodr\u00edguez-Nu\u00f1ez O, Rico V, et al. Factors associated with short-term eradication of KPC-KP colonization. Front Microbiol. 2021;12:630826.","journal-title":"Front Microbiol"},{"key":"2718_CR42","doi-asserted-by":"publisher","first-page":"1517772","DOI":"10.3389\/fmicb.2025.1517772","volume":"16","author":"A Karnwal","year":"2025","unstructured":"Karnwal A, Jassim AY, Mohammed AA, et al. Strategies against bacterial drug resistance. Front Microbiol. 2025;16:1517772.","journal-title":"Front Microbiol"},{"key":"2718_CR43","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1097\/MIB.0000000000000893","volume":"22","author":"BP Vaughn","year":"2016","unstructured":"Vaughn BP, Vatanen T, Allegretti JR, et al. Increased gut diversity after FMT for Crohn\u2019s disease. Inflamm Bowel Dis. 2016;22:2182\u201390.","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"2718_CR44","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1053\/j.gastro.2018.12.019","volume":"156","author":"CL Hvas","year":"2019","unstructured":"Hvas CL, Dahl Jorgensen SM, Jorgensen SP, et al. FMT vs fidaxomicin for recurrent C difficile. Gastroenterology. 2019;156(6):1324\u201332.","journal-title":"Gastroenterology"},{"key":"2718_CR45","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13756-022-01064-4","volume":"11","author":"J Hyun","year":"2022","unstructured":"Hyun J, Lee SK, Cheon JH, et al. FMT reduces ARG abundance in MDRO carriers. Antimicrob Resist Infect Control. 2022;11:20.","journal-title":"Antimicrob Resist Infect Control"},{"key":"2718_CR46","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1080\/07853890.2019.1662477","volume":"51","author":"YK Yoon","year":"2019","unstructured":"Yoon YK, Suh JW, Kang EJ, et al. FMT for MDRO decolonization. Ann Med. 2019;51:379\u201389.","journal-title":"Ann Med"},{"key":"2718_CR47","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.jinf.2022.04.028","volume":"84","author":"J Macare\u00f1o-Castro","year":"2022","unstructured":"Macare\u00f1o-Castro J, Solano-Salazar A, Dong LT, et al. FMT for CRE: systematic review. J Infect. 2022;84:749\u201359.","journal-title":"J Infect"},{"key":"2718_CR48","doi-asserted-by":"crossref","first-page":"1012.e1","DOI":"10.1016\/j.cmi.2019.04.006","volume":"25","author":"S Saha","year":"2019","unstructured":"Saha S, Tariq R, Tosh PK, et al. FMT for eradication of MDRO carriage. Clin Microbiol Infect. 2019;25:1012.e1-1012.e5.","journal-title":"Clin Microbiol Infect"},{"key":"2718_CR49","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.cmi.2018.12.009","volume":"25","author":"BD Huttner","year":"2019","unstructured":"Huttner BD, de Lastours V, Wassenberg M, et al. Oral antibiotics + FMT for MDR-E eradication: RCT. Clin Microbiol Infect. 2019;25:830\u20138.","journal-title":"Clin Microbiol Infect"},{"issue":"720","key":"2718_CR50","doi-asserted-by":"publisher","first-page":"eabo2750","DOI":"10.1126\/scitranslmed.abo2750","volume":"15","author":"MH Woodworth","year":"2023","unstructured":"Woodworth MH, Conrad RE, Haldopoulos M, et al. FMT promotes ARG reduction by strain replacement. Sci Transl Med. 2023;15(720):eabo2750.","journal-title":"Sci Transl Med"},{"key":"2718_CR51","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s12879-015-0973-1","volume":"15","author":"Y Wei","year":"2015","unstructured":"Wei Y, Gong J, Zhu W, et al. FMT for MRSA enterocolitis. BMC Infect Dis. 2015;15:265.","journal-title":"BMC Infect Dis"},{"key":"2718_CR52","doi-asserted-by":"publisher","unstructured":"Dubberke ER, Mullane KM, Gerding DN, et al. Clearance of VRE with microbiota-based therapy. Open Forum Infect Dis. 2016;3(3);ofw133. https:\/\/doi.org\/10.1093\/ofid\/ofw133.","DOI":"10.1093\/ofid\/ofw133"},{"key":"2718_CR53","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.medmal.2018.11.002","volume":"49","author":"B Davido","year":"2019","unstructured":"Davido B, Batista R, Fessi H, et al. FMT to eradicate VRE during outbreak. Med Mal Infect. 2019;49:214\u20138.","journal-title":"Med Mal Infect"},{"key":"2718_CR54","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1017\/ice.2016.229","volume":"37","author":"KM Sohn","year":"2016","unstructured":"Sohn KM, Cheon S, Kim YS. FMT to eradicate VRE colonization. Infect Control Hosp Epidemiol. 2016;37:1519\u201321.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2718_CR55","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.3390\/biomedicines10102404","volume":"10","author":"J Shin","year":"2022","unstructured":"Shin J, Lee JH, Park SH, et al. FMT for MDRO clearance: prospective comparative trial. Biomedicines. 2022;10:2404.","journal-title":"Biomedicines"},{"key":"2718_CR56","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/MOG.0000000000000792","volume":"38","author":"MP Bilsen","year":"2022","unstructured":"Bilsen MP, Lambregts MMC, van Prehn J, et al. FMT to eradicate AMR bacteria: systematic review. Curr Opin Gastroenterol. 2022;38:15\u201325.","journal-title":"Curr Opin Gastroenterol"},{"key":"2718_CR57","doi-asserted-by":"publisher","first-page":"106504","DOI":"10.1016\/j.jinf.2025.106504","volume":"91","author":"B Merrick","year":"2025","unstructured":"Merrick B, Prossomariti D, Allen E, et al. Faecal microbiota transplant to eradicate gastrointestinal carriage of antibiotic-resistant organisms (FERARO): feasibility randomised controlled trial. J Infect. 2025;91:106504. https:\/\/doi.org\/10.1016\/j.jinf.2025.106504.","journal-title":"J Infect"},{"key":"2718_CR58","doi-asserted-by":"publisher","first-page":"941","DOI":"10.3390\/microorganisms8060941","volume":"8","author":"S Leo","year":"2020","unstructured":"Leo S, Lazarevic V, Girard M, et al. Metagenomic characterization of gut microbiota of carriers of ESBL or carbapenemase-producing Enterobacteriaceae following oral antibiotics and FMT: multicenter randomized trial. Microorganisms. 2020;8:941.","journal-title":"Microorganisms"},{"key":"2718_CR59","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s13104-018-3293-x","volume":"11","author":"R Singh","year":"2018","unstructured":"Singh R, de Groot PF, Geerlings SE, et al. FMT against intestinal colonization by ESBL-producing Enterobacteriaceae: proof-of-principle study. BMC Res Notes. 2018;11:190.","journal-title":"BMC Res Notes"},{"key":"2718_CR60","doi-asserted-by":"publisher","first-page":"e166","DOI":"10.1093\/cid\/ciaa737","volume":"73","author":"H Bar-Yoseph","year":"2021","unstructured":"Bar-Yoseph H, Carasso S, Shklar S, et al. Oral capsulized FMT for eradication of carbapenemase-producing Enterobacteriaceae colonization: metagenomic perspective. Clin Infect Dis. 2021;73:e166\u201375.","journal-title":"Clin Infect Dis"},{"key":"2718_CR61","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3390\/microorganisms9020352","volume":"9","author":"JJ Lee","year":"2021","unstructured":"Lee JJ, Yong D, Suk KT, et al. Alteration of gut microbiota in CRE carriers during FMT according to decolonization periods. Microorganisms. 2021;9:352.","journal-title":"Microorganisms"},{"key":"2718_CR62","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.ijantimicag.2018.11.014","volume":"53","author":"N Sa\u00efdani","year":"2019","unstructured":"Sa\u00efdani N, Lagier JC, Cassir N, et al. FMT shortens colonization with carbapenemase-producing bacteria and facilitates return to care facilities. Int J Antimicrob Agents. 2019;53:355\u201361.","journal-title":"Int J Antimicrob Agents"},{"key":"2718_CR63","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.3324\/haematol.2019.244210","volume":"105","author":"P Merli","year":"2020","unstructured":"Merli P, Putignani L, Ruggeri A, et al. Decolonization of multidrug-resistant bacteria by FMT in pediatric patients before allo-HSCT: microbiota profiling and outcomes. Haematologica. 2020;105:2686\u201390.","journal-title":"Haematologica"},{"key":"2718_CR64","doi-asserted-by":"publisher","first-page":"925","DOI":"10.17235\/reed.2020.7150\/2020","volume":"112","author":"JC Silva","year":"2020","unstructured":"Silva JC, Ponte A, Mota M, et al. FMT in the decolonization of carbapenemase-producing Enterobacteriaceae. Rev Esp Enferm Dig. 2020;112:925\u20138.","journal-title":"Rev Esp Enferm Dig"},{"key":"2718_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.idcr.2018.e00432","volume":"13","author":"C Dias","year":"2018","unstructured":"Dias C, Pipa S, Duarte-Ribeiro F, et al. Fecal microbiota transplantation as a potential way to eradicate multiresistant microorganisms. IDCases. 2018;13:e00432.","journal-title":"IDCases"},{"key":"2718_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0300060520925693","volume":"48","author":"MM Biernat","year":"2020","unstructured":"Biernat MM, Urbaniak-Kujda D, Dybko J, et al. FMT for intestinal steroid-resistant GVHD: two case reports and review. J Int Med Res. 2020;48:1\u201311.","journal-title":"J Int Med Res"},{"key":"2718_CR67","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13386","volume":"23","author":"J Bilinski","year":"2021","unstructured":"Bilinski J, Lis K, Tomaszewska A, et al. Eosinophilic gastroenteritis and GVHD induced by norovirus transmission via FMT. Transpl Infect Dis. 2021;23:e13386.","journal-title":"Transpl Infect Dis"},{"key":"2718_CR68","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40001-021-00508-8","volume":"26","author":"F Su","year":"2021","unstructured":"Su F, Luo Y, Yu J, et al. Tandem FMT cycles to target CRE colonization in an allo-HSCT recipient: case report and review. Eur J Med Res. 2021;26:37.","journal-title":"Eur J Med Res"},{"key":"2718_CR69","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.2147\/IDR.S308308","volume":"14","author":"J Wang","year":"2021","unstructured":"Wang J, Li X, Wu X, et al. FMT as effective treatment for carbapenem-resistant Klebsiella pneumoniae infection in a renal transplant patient. Infect Drug Resist. 2021;14:1805\u201311.","journal-title":"Infect Drug Resist"},{"issue":"720","key":"2718_CR70","doi-asserted-by":"publisher","first-page":"eabo2750","DOI":"10.1126\/scitranslmed.abo2750","volume":"15","author":"MH Woodworth","year":"2023","unstructured":"Woodworth MH, Conrad RE, Haldopoulos M, Pouch SM, Babiker A, Mehta AK, et al. Fecal microbiota transplantation promotes reduction of antimicrobial resistance by strain replacement. Sci Transl Med. 2023;15(720):eabo2750. https:\/\/doi.org\/10.1126\/scitranslmed.abo2750.","journal-title":"Sci Transl Med"},{"issue":"4","key":"2718_CR71","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.jhin.2017.02.001","volume":"95","author":"B Davido","year":"2017","unstructured":"Davido B, Batista R, Michelon H, Lepainteur M, Bouchand F, Lepeule R, et al. Is faecal microbiota transplantation an option to eradicate highly drug-resistant enteric bacteria carriage? J Hosp Infect. 2017;95(4):433\u20137.","journal-title":"J Hosp Infect"},{"issue":"3","key":"2718_CR72","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1093\/cid\/cix252","volume":"65","author":"J Bilinski","year":"2017","unstructured":"Bilinski J, Grzesiowski P, Sorensen N, Madry K, Muszynski J, Robak K, et al. Fecal microbiota transplantation in patients with blood disorders inhibits gut colonization with antibiotic-resistant bacteria: results of a prospective, single-center study. Clin Infect Dis. 2017;65(3):364\u201370.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"2718_CR73","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.jhin.2018.02.018","volume":"99","author":"A Dinh","year":"2018","unstructured":"Dinh A, Fessi H, Duran C, Batista R, Michelon H, Bouchand F, et al. Clearance of carbapenem-resistant Enterobacteriaceae vs vancomycin-resistant enterococci carriage after faecal microbiota transplant: a prospective comparative study. J Hosp Infect. 2018;99(4):481\u20136.","journal-title":"J Hosp Infect"},{"issue":"8","key":"2718_CR74","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.3324\/haematol.2018.198549","volume":"104","author":"G Battipaglia","year":"2019","unstructured":"Battipaglia G, Malard F, Rubio MT, Ruggeri A, Mamez AC, Brissot E, et al. Fecal microbiota transplantation before or after allogeneic hematopoietic transplantation in patients with hematologic malignancies carrying multidrug-resistance bacteria. Haematologica. 2019;104(8):1682\u20138.","journal-title":"Haematologica"},{"key":"2718_CR75","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1093\/cid\/ciaa948","volume":"72","author":"R Ghani","year":"2021","unstructured":"Ghani R, Mullish BH, McDonald JAK, Ghazy A, Williams HRT, Brannigan ET, et al. Disease prevention not decolonization: a model for fecal microbiota transplantation in patients colonized with multidrug-resistant organisms. Clin Infect Dis. 2021;72:1444\u20137.","journal-title":"Clin Infect Dis"},{"key":"2718_CR76","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jinf.2020.09.003","volume":"81","author":"H Seong","year":"2020","unstructured":"Seong H, Lee SK, Cheon JH, Yong DE, Koh H, Kang YK, et al. Fecal microbiota transplantation for multidrug-resistant organism: efficacy and response prediction. J Infect. 2020;81:719\u201325.","journal-title":"J Infect"},{"issue":"16","key":"2718_CR77","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1001\/jama.2023.4314","volume":"329","author":"T Louie","year":"2023","unstructured":"Louie T, Golan Y, Khanna S, Bobilev D, Erpelding N, Fratazzi C, et al. VE303, a defined bacterial consortium, for prevention of recurrent Clostridioides difficile infection: a randomized clinical trial. JAMA. 2023;329(16):1356\u201366. https:\/\/doi.org\/10.1001\/jama.2023.4314.","journal-title":"JAMA"},{"issue":"8","key":"2718_CR78","doi-asserted-by":"publisher","DOI":"10.1093\/femsle\/fnv012","volume":"362","author":"L Crouzet","year":"2015","unstructured":"Crouzet L, Rigottier-Gois L, Serror P. Potential use of probiotic and commensal bacteria as non-antibiotic strategies against vancomycin-resistant enterococci. FEMS Microbiol Lett. 2015;362(8):fnv012. https:\/\/doi.org\/10.1093\/femsle\/fnv012.","journal-title":"FEMS Microbiol Lett"},{"issue":"4","key":"2718_CR79","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.ijantimicag.2012.06.006","volume":"40","author":"K Kotzampassi","year":"2012","unstructured":"Kotzampassi K, Giamarellos-Bourboulis EJ. Probiotics for infectious diseases: more drugs, less dietary supplementation. Int J Antimicrob Agents. 2012;40(4):288\u201396. https:\/\/doi.org\/10.1016\/j.ijantimicag.2012.06.006.","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"2718_CR80","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1046\/j.1365-2036.2003.01638.x","volume":"18","author":"J Boudeau","year":"2003","unstructured":"Boudeau J, Glasser AL, Julien S, Colombel JF, Darfeuille-Michaud A. Inhibitory effect of probiotic Escherichia coli strain Nissle 1917 on adhesion to and invasion of intestinal epithelial cells by adherent-invasive E. coli strains isolated from patients with Crohn\u2019s disease. Aliment Pharmacol Ther. 2003;18(1):45\u201356. https:\/\/doi.org\/10.1046\/j.1365-2036.2003.01638.x.","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"2718_CR81","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1099\/JMM.0.025874-0","volume":"60","author":"GW Tannock","year":"2011","unstructured":"Tannock GW, Tiong IS, Priest P, et al. Testing probiotic strain Escherichia coli Nissle 1917 (Mutaflor) for its ability to reduce carriage of multidrug-resistant E. coli by elderly residents in long-term care facilities. J Med Microbiol. 2011;60(3):366\u201370. https:\/\/doi.org\/10.1099\/JMM.0.025874-0.","journal-title":"J Med Microbiol"},{"issue":"4","key":"2718_CR82","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.cmi.2019.08.019","volume":"26","author":"O Ljungquist","year":"2020","unstructured":"Ljungquist O, Kampmann C, Resman F, Riesbeck K, Tham J. Probiotics for intestinal decolonization of ESBL-producing Enterobacteriaceae: a randomized, placebo-controlled clinical trial. Clin Microbiol Infect. 2020;26(4):456\u201362. https:\/\/doi.org\/10.1016\/j.cmi.2019.08.019.","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"2718_CR83","doi-asserted-by":"publisher","first-page":"e23686","DOI":"10.1097\/MD.0000000000023686","volume":"100","author":"E Choi","year":"2021","unstructured":"Choi E, Lee SJ, Lee S, Yi J, Lee YS, Chang SY, et al. Comprehensive, multisystem, mechanical decolonization of vancomycin-resistant Enterococcus and carbapenem-resistant Enterobacteriaceae without the use of antibiotics. Medicine (Baltimore). 2021;100(3):e23686. https:\/\/doi.org\/10.1097\/MD.0000000000023686.","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"2718_CR84","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1080\/14767058.2020.1743671","volume":"35","author":"M Buyukeren","year":"2020","unstructured":"Buyukeren M, Yigit S, Buyukcam A, Kara A, Celik HT, Yurdakok M. A new use of Lactobacillus rhamnosus GG administration in the NICU: colonized vancomycin-resistant Enterococcus eradication in the gastrointestinal system. J Matern Fetal Neonatal Med. 2020;35(6):1192\u20138. https:\/\/doi.org\/10.1080\/14767058.2020.1743671.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2718_CR85","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1097\/MCG.0b013e318227439f","volume":"45","author":"P Szachta","year":"2011","unstructured":"Szachta P, Ignys I, Cichy W. An evaluation of the ability of the probiotic strain Lactobacillus rhamnosus GG to eliminate the gastrointestinal carrier state of vancomycin-resistant enterococci in colonized children. J Clin Gastroenterol. 2011;45:872\u20137. https:\/\/doi.org\/10.1097\/MCG.0b013e318227439f.","journal-title":"J Clin Gastroenterol"},{"key":"2718_CR86","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.00473-10","author":"M Vidal","year":"2010","unstructured":"Vidal M, Forestier C, Charbonnel N, Henard S, Rabaud C, Lesens O. Probiotics and intestinal colonization by vancomycin-resistant enterococci in mice and humans. J Clin Microbiol. 2010. https:\/\/doi.org\/10.1128\/jcm.00473-10.","journal-title":"J Clin Microbiol"},{"key":"2718_CR87","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1186\/1471-2334-14-514","volume":"14","author":"VC Cheng","year":"2014","unstructured":"Cheng VC, Chen JH, Tai JW, et al. Decolonization of gastrointestinal carriage of vancomycin-resistant Enterococcus faecium: case series and review of literature. BMC Infect Dis. 2014;14:514. https:\/\/doi.org\/10.1186\/1471-2334-14-514.","journal-title":"BMC Infect Dis"},{"key":"2718_CR88","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.3390\/microorganisms11102393","volume":"11","author":"M Jain","year":"2023","unstructured":"Jain M, Stitt G, Son L, Enioutina EY. Probiotics and their bioproducts: a promising approach for targeting methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus. Microorganisms. 2023;11:2393. https:\/\/doi.org\/10.3390\/microorganisms11102393.","journal-title":"Microorganisms"},{"issue":"8","key":"2718_CR89","doi-asserted-by":"publisher","first-page":"4593","DOI":"10.1128\/AAC.00300-15","volume":"59","author":"S Doron","year":"2015","unstructured":"Doron S, Hibberd PL, Goldin B, Thorpe C, McDermott L, Snydman DR. Effect of Lactobacillus rhamnosus GG administration on vancomycin-resistant Enterococcus colonization in adults with comorbidities. Antimicrob Agents Chemother. 2015;59(8):4593\u20139. https:\/\/doi.org\/10.1128\/AAC.00300-15.","journal-title":"Antimicrob Agents Chemother"},{"key":"2718_CR90","doi-asserted-by":"publisher","first-page":"e02348-21","DOI":"10.1128\/spectrum.02348-21","volume":"10","author":"IMC Rubin","year":"2022","unstructured":"Rubin IMC, Mollerup S, Broholm C, Knudsen SB, Baker A, Helms M, et al. No effect of Lactobacillus rhamnosus GG on eradication of colonization by vancomycin-resistant Enterococcus faecium or microbiome diversity in hospitalized adult patients. Microbiol Spectr. 2022;10:e02348-21. https:\/\/doi.org\/10.1128\/spectrum.02348-21.","journal-title":"Microbiol Spectr"},{"key":"2718_CR91","doi-asserted-by":"publisher","first-page":"454","DOI":"10.5694\/j.1326-5377.2007.tb00995.x","volume":"186","author":"KJ Manley","year":"2007","unstructured":"Manley KJ, Fraenkel MB, Mayall BC, Power DA. Probiotic treatment of vancomycin-resistant enterococci: a randomized controlled trial. Med J Aust. 2007;186:454\u20137.","journal-title":"Med J Aust"},{"key":"2718_CR92","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3920\/BM2013.0062","volume":"5","author":"S Warrack","year":"2014","unstructured":"Warrack S, Panjikar P, Duster M, Safdar N. Tolerability of a probiotic in subjects with a history of methicillin-resistant Staphylococcus aureus colonisation. Benef Microbes. 2014;5:389\u201395.","journal-title":"Benef Microbes"},{"key":"2718_CR93","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12879-018-3028-6","volume":"18","author":"S Eggers","year":"2018","unstructured":"Eggers S, Barker AK, Valentine S, Hess T, Duster M, Safdar N. Effect of Lactobacillus rhamnosus HN001 on carriage of Staphylococcus aureus: results of the impact of probiotics for reducing infections in veterans (IMPROVE) study. BMC Infect Dis. 2018;18:129.","journal-title":"BMC Infect Dis"},{"key":"2718_CR94","doi-asserted-by":"publisher","first-page":"e75","DOI":"10.1016\/S2666-5247(22)00322-6","volume":"4","author":"P Piewngam","year":"2023","unstructured":"Piewngam P, Khongthong S, Roekngam N, Theapparat Y, Sunpaweravong S, Faroongsarng D, et al. Probiotic for pathogen-specific Staphylococcus aureus decolonisation in Thailand: a phase 2, double-blind, randomised, placebo-controlled trial. Lancet Microbe. 2023;4:e75\u201383.","journal-title":"Lancet Microbe"},{"key":"2718_CR95","doi-asserted-by":"publisher","first-page":"S399","DOI":"10.14309\/00000434-201310001-01342","volume":"108","author":"A Kalakonda","year":"2013","unstructured":"Kalakonda A, Garg S, Tandon S, Kaur S, Vinayek R, Dutta S. MRSA colitis: an uncommon manifestation of a common pathogen. Am J Gastroenterol. 2013;108:S399.","journal-title":"Am J Gastroenterol"},{"key":"2718_CR96","doi-asserted-by":"publisher","first-page":"2356279","DOI":"10.1080\/19490976.2024.2356279","volume":"16","author":"MN Rahman","year":"2024","unstructured":"Rahman MN, Barua N, Tin MCF, Dharmaratne P, Wong SH, Ip M. The use of probiotics and prebiotics in decolonizing pathogenic bacteria from the gut; a systematic review and meta-analysis of clinical outcomes. Gut Microbes. 2024;16:2356279. https:\/\/doi.org\/10.1080\/19490976.2024.2356279.","journal-title":"Gut Microbes"},{"key":"2718_CR97","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1017\/ice.2021.94","volume":"43","author":"AM Rauseo","year":"2022","unstructured":"Rauseo AM, Hink T, Reske KA, Seiler SM, Bommarito KM, Fraser VJ, et al. A randomized controlled trial of Lactobacillus rhamnosus GG on antimicrobial-resistant organism colonization. Infect Control Hosp Epidemiol. 2022;43:167\u201373. https:\/\/doi.org\/10.1017\/ice.2021.94.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2718_CR98","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01765-09","author":"MJA de Regt","year":"2010","unstructured":"de Regt MJA, Willems RJL, Hen\u00e9 RJ, Siersema PD, Verhaar HJJ, Hopmans TEM, et al. Effects of probiotics on acquisition and spread of multiresistant enterococci. Antimicrob Agents Chemother. 2010. https:\/\/doi.org\/10.1128\/aac.01765-09.","journal-title":"Antimicrob Agents Chemother"},{"key":"2718_CR99","doi-asserted-by":"publisher","first-page":"bcr2012006366","DOI":"10.1136\/bcr-2012-006366","volume":"2012","author":"EN Sizemore","year":"2012","unstructured":"Sizemore EN, Rivas KM, Valdes J, Caballero J. Enteral vancomycin and probiotic use for methicillin-resistant Staphylococcus aureus antibiotic-associated diarrhoea. BMJ Case Rep. 2012;2012:bcr2012006366. https:\/\/doi.org\/10.1136\/bcr-2012-006366.","journal-title":"BMJ Case Rep"},{"key":"2718_CR100","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nrgastro.2017.75","volume":"14","author":"GR Gibson","year":"2017","unstructured":"Gibson GR, Hutkins R, Sanders ME, et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol. 2017;14:491\u2013502. https:\/\/doi.org\/10.1038\/nrgastro.2017.75.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2718_CR101","doi-asserted-by":"publisher","first-page":"3928","DOI":"10.1007\/s12010-022-04104-2","volume":"195","author":"S Park","year":"2023","unstructured":"Park S, Saravanakumar K, Sathiyaseelan A, Han KS, Lee J, Wang MH. Polysaccharides of Weissella cibaria act as a prebiotic to enhance the probiotic potential of Lactobacillus rhamnosus. Appl Biochem Biotechnol. 2023;195:3928\u201340. https:\/\/doi.org\/10.1007\/s12010-022-04104-2.","journal-title":"Appl Biochem Biotechnol"},{"key":"2718_CR102","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1590\/0037-8682-0233-2016","volume":"49","author":"MC Salom\u00e3o","year":"2016","unstructured":"Salom\u00e3o MC, Heluany-Filho MA, Menegueti MG, Kraker ME, Martinez R, Bellissimo-Rodrigues F. A randomized clinical trial on the effectiveness of a symbiotic product to decolonize patients harboring multidrug-resistant Gram-negative bacilli. Rev Soc Bras Med Trop. 2016;49:559\u201366.","journal-title":"Rev Soc Bras Med Trop"},{"key":"2718_CR103","doi-asserted-by":"publisher","first-page":"e489","DOI":"10.1016\/S2666-5247(24)00002-8","volume":"5","author":"Q Fang","year":"2024","unstructured":"Fang Q, et al. Safety and efficacy of phage application in bacterial decolonisation: a systematic review. Lancet Microbe. 2024;5:e489\u201399.","journal-title":"Lancet Microbe"},{"key":"2718_CR104","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1007\/BF02932128","volume":"51","author":"P Leszczynski","year":"2006","unstructured":"Leszczynski P, Weber-Dabrowska B, Kohutnicka M, et al. Successful eradication of methicillin-resistant Staphylococcus aureus (MRSA) intestinal carrier status in a healthcare worker \u2013 case report. Folia Microbiol (Praha). 2006;51:236\u20138.","journal-title":"Folia Microbiol (Praha)"},{"key":"2718_CR105","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1093\/cid\/ciz782","volume":"70","author":"M Corbellino","year":"2020","unstructured":"Corbellino M, Kieffer N, Kutateladze M, et al. Eradication of a multidrug-resistant, carbapenemase-producing Klebsiella pneumoniae isolate following oral and intra-rectal therapy with a custom made, lytic bacteriophage preparation. Clin Infect Dis. 2020;70:1998\u20132001.","journal-title":"Clin Infect Dis"},{"key":"2718_CR106","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics13080747","volume":"13","author":"MJS Knudsen","year":"2024","unstructured":"Knudsen MJS, Rubin IMC, Petersen AM. The effect of antibiotics on the eradication of multidrug-resistant organisms in intestinal carriers\u2014a systematic review with meta-analysis. Antibiotics. 2024;13:747. https:\/\/doi.org\/10.3390\/antibiotics13080747.","journal-title":"Antibiotics"},{"key":"2718_CR107","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.cmi.2019.01.005","volume":"25","author":"E Tacconelli","year":"2019","unstructured":"Tacconelli E, Mazzaferri F, de Smet AM, et al. ESCMID-EUCIC clinical guidelines on decolonization of multidrug-resistant Gram-negative bacteria carriers. Clin Microbiol Infect. 2019;25:807\u201317. https:\/\/doi.org\/10.1016\/j.cmi.2019.01.005.","journal-title":"Clin Microbiol Infect"},{"key":"2718_CR108","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1001\/archsurg.140.8.752","volume":"140","author":"SM Wren","year":"2005","unstructured":"Wren SM, Ahmed N, Jamal A, Safadi BY. Preoperative oral antibiotics in colorectal surgery increase the rate of Clostridium difficile colitis. Arch Surg. 2005;140:752\u20136. https:\/\/doi.org\/10.1001\/archsurg.140.8.752.","journal-title":"Arch Surg"},{"key":"2718_CR109","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3390\/pharmaceutics13020196","volume":"13","author":"G Gradisteanu Pircalabioru","year":"2021","unstructured":"Gradisteanu Pircalabioru G, Popa LI, Marutescu L, et al. Bacteriocins in the era of antibiotic resistance: rising to the challenge. Pharmaceutics. 2021;13:196. https:\/\/doi.org\/10.3390\/pharmaceutics13020196.","journal-title":"Pharmaceutics"},{"key":"2718_CR110","first-page":"1","volume":"200","author":"S Hempel","year":"2011","unstructured":"Hempel S, Newberry S, Ruelaz A, et al. Safety of probiotics used to reduce risk and prevent or treat disease. Evid Rep Technol Assess (Full Rep). 2011;200:1\u2013645.","journal-title":"Evid Rep Technol Assess (Full Rep)"},{"key":"2718_CR111","doi-asserted-by":"publisher","first-page":"e058124","DOI":"10.1136\/bmjopen-2021-058124","volume":"12","author":"E P\u00e9rez-Nadales","year":"2022","unstructured":"P\u00e9rez-Nadales E, Cano \u00c1, Recio M, et al. Randomised, double-blind, placebo-controlled, phase 2, superiority trial to demonstrate the effectiveness of faecal microbiota transplantation for selective intestinal decolonisation of patients colonised by carbapenemase-producing Klebsiella pneumoniae (KAPEDIS). BMJ Open. 2022;12:e058124. https:\/\/doi.org\/10.1136\/bmjopen-2021-058124.","journal-title":"BMJ Open"},{"key":"2718_CR112","doi-asserted-by":"publisher","first-page":"e0006022","DOI":"10.1128\/cmr.00060-22","volume":"37","author":"A Yadegar","year":"2024","unstructured":"Yadegar A, Bar-Yoseph H, Monaghan TM, et al. Fecal microbiota transplantation: current challenges and future landscapes. Clin Microbiol Rev. 2024;37:e0006022.","journal-title":"Clin Microbiol Rev"},{"key":"2718_CR113","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1056\/NEJMoa1910437","volume":"381","author":"Z DeFilipp","year":"2019","unstructured":"DeFilipp Z, Bloom PP, Torres Soto M, et al. Drug-resistant E. coli bacteremia transmitted by fecal microbiota transplant. N Engl J Med. 2019;381:2043\u201350.","journal-title":"N Engl J Med"},{"key":"2718_CR114","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1007\/s00108-022-01399-5","volume":"63","author":"A Stallmach","year":"2022","unstructured":"Stallmach A, Steube A, Stallhofer J, et al. F\u00e4kaler Mikrobiomtransfer\u2014Indikationen, Risiken und Chancen [Fecal microbiota transplantation: indications, risks and opportunities]. Inn Med (Heidelb). 2022;63:1036\u201342. https:\/\/doi.org\/10.1007\/s00108-022-01399-5.","journal-title":"Inn Med (Heidelb)"},{"key":"2718_CR115","doi-asserted-by":"publisher","first-page":"175628481984300","DOI":"10.1177\/1756284819843002","volume":"12","author":"E Dehlholm-Lambertsen","year":"2019","unstructured":"Dehlholm-Lambertsen E, Hall BK, J\u00f8rgensen SMD, et al. Cost savings following faecal microbiota transplantation for recurrent Clostridium difficile infection. Therap Adv Gastroenterol. 2019;12:1756284819843002. https:\/\/doi.org\/10.1177\/1756284819843002.","journal-title":"Therap Adv Gastroenterol"},{"key":"2718_CR116","doi-asserted-by":"publisher","first-page":"e1599","DOI":"10.7759\/cureus.1599","volume":"9","author":"LT Arbel","year":"2017","unstructured":"Arbel LT, Hsu E, McNally K. Cost-effectiveness of fecal microbiota transplantation in the treatment of recurrent Clostridium difficile infection: a literature review. Cureus. 2017;9:e1599. https:\/\/doi.org\/10.7759\/cureus.1599.","journal-title":"Cureus"},{"key":"2718_CR117","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.chom.2020.06.002","volume":"28","author":"M Louren\u00e7o","year":"2020","unstructured":"Louren\u00e7o M, Chaffringeon L, Lamy-Besnier Q, et al. The spatial heterogeneity of the gut limits predation and fosters coexistence of bacteria and bacteriophages. Cell Host Microbe. 2020;28:390-401.e5. https:\/\/doi.org\/10.1016\/j.chom.2020.06.002.","journal-title":"Cell Host Microbe"},{"key":"2718_CR118","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41385-019-0250-5","volume":"13","author":"R Sausset","year":"2020","unstructured":"Sausset R, Petit MA, Gaboriau-Routhiau V, et al. New insights into intestinal phages. Mucosal Immunol. 2020;13:205\u201315. https:\/\/doi.org\/10.1038\/s41385-019-0250-5.","journal-title":"Mucosal Immunol"},{"key":"2718_CR119","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.03474-20","volume":"12","author":"SI Green","year":"2021","unstructured":"Green SI, Gu Liu C, Yu X, et al. Targeting of mammalian glycans enhances phage predation in the gastrointestinal tract. MBio. 2021;12:e03474-20. https:\/\/doi.org\/10.1128\/mBio.03474-20.","journal-title":"MBio"},{"key":"2718_CR120","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1002\/med.21572","volume":"39","author":"K D\u0105browska","year":"2019","unstructured":"D\u0105browska K. Phage therapy: what factors shape phage pharmacokinetics and bioavailability? Systematic and critical review. Med Res Rev. 2019;39:2000\u201325. https:\/\/doi.org\/10.1002\/med.21572.","journal-title":"Med Res Rev"},{"key":"2718_CR121","doi-asserted-by":"publisher","first-page":"4783","DOI":"10.3390\/v7082845","volume":"7","author":"J Majewska","year":"2015","unstructured":"Majewska J, Beta W, Lecion D, et al. Oral application of T4 phage induces weak antibody production in the gut and in the blood. Viruses. 2015;7:4783\u201399. https:\/\/doi.org\/10.3390\/v7082845.","journal-title":"Viruses"},{"key":"2718_CR122","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3390\/v10060323","volume":"10","author":"C Torres-Barcel\u00f3","year":"2018","unstructured":"Torres-Barcel\u00f3 C. Phage therapy faces evolutionary challenges. Viruses. 2018;10:323. https:\/\/doi.org\/10.3390\/v10060323.","journal-title":"Viruses"},{"key":"2718_CR123","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41579-019-0278-2","volume":"18","author":"A Bernheim","year":"2020","unstructured":"Bernheim A, Sorek R. The pan-immune system of bacteria: antiviral defence as a community resource. Nat Rev Microbiol. 2020;18:113\u20139. https:\/\/doi.org\/10.1038\/s41579-019-0278-2.","journal-title":"Nat Rev Microbiol"},{"key":"2718_CR124","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3390\/v10070351","volume":"10","author":"F Oechslin","year":"2018","unstructured":"Oechslin F. Resistance development to bacteriophages occurring during bacteriophage therapy. Viruses. 2018;10:351. https:\/\/doi.org\/10.3390\/v10070351.","journal-title":"Viruses"},{"key":"2718_CR125","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1038\/s41591-025-03678-8","volume":"31","author":"BK Chan","year":"2025","unstructured":"Chan BK, Stanley GL, Kortright KE, et al. Personalized inhaled bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa in cystic fibrosis. Nat Med. 2025;31:1494\u2013501. https:\/\/doi.org\/10.1038\/s41591-025-03678-8.","journal-title":"Nat Med"},{"key":"2718_CR126","doi-asserted-by":"publisher","DOI":"10.1099\/mic.0.001491","volume":"170","author":"AR Burmeister","year":"2024","unstructured":"Burmeister AR, Tewatia H, Skinner C. A tradeoff between bacteriophage resistance and bacterial motility is mediated by the Rcs phosphorelay in Escherichia coli. Microbiology (Reading). 2024;170:001491. https:\/\/doi.org\/10.1099\/mic.0.001491.","journal-title":"Microbiology (Reading)"},{"key":"2718_CR127","doi-asserted-by":"publisher","first-page":"11207","DOI":"10.1073\/pnas.1919888117","volume":"117","author":"AR Burmeister","year":"2020","unstructured":"Burmeister AR, Fortier A, Roush C, et al. Pleiotropy complicates a trade-off between phage resistance and antibiotic resistance. Proc Natl Acad Sci U S A. 2020;117:11207\u201316. https:\/\/doi.org\/10.1073\/pnas.1919888117.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2718_CR128","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.00812-15","author":"J Colom","year":"2015","unstructured":"Colom J, Cano-Sarabia M, Otero J, et al. Liposome-encapsulated bacteriophages for enhanced oral phage therapy against Salmonella spp. Appl Environ Microbiol. 2015. https:\/\/doi.org\/10.1128\/AEM.00812-15.","journal-title":"Appl Environ Microbiol"},{"key":"2718_CR129","doi-asserted-by":"publisher","first-page":"689","DOI":"10.3389\/fmicb.2019.00689","volume":"10","author":"J Otero","year":"2019","unstructured":"Otero J, Garc\u00eda-Rodr\u00edguez A, Cano-Sarabia M, et al. Biodistribution of liposome-encapsulated bacteriophages and their transcytosis during oral phage therapy. Front Microbiol. 2019;10:689. https:\/\/doi.org\/10.3389\/fmicb.2019.00689.","journal-title":"Front Microbiol"},{"key":"2718_CR130","doi-asserted-by":"publisher","first-page":"41441","DOI":"10.1038\/srep41441","volume":"7","author":"J Colom","year":"2017","unstructured":"Colom J, Cano-Sarabia M, Otero J, et al. Microencapsulation with alginate\/CaCO3: a strategy for improved phage therapy. Sci Rep. 2017;7:41441. https:\/\/doi.org\/10.1038\/srep41441.","journal-title":"Sci Rep"},{"key":"2718_CR131","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.foodhyd.2010.11.017","volume":"26","author":"Y Ma","year":"2012","unstructured":"Ma Y, Pacan JC, Wang Q, et al. Enhanced alginate microspheres as means of oral delivery of bacteriophage for reducing Staphylococcus aureus intestinal carriage. Food Hydrocolloids. 2012;26:434\u201340. https:\/\/doi.org\/10.1016\/j.foodhyd.2010.11.017.","journal-title":"Food Hydrocolloids"},{"key":"2718_CR132","doi-asserted-by":"publisher","first-page":"4799","DOI":"10.1128\/AEM.00246-08","volume":"74","author":"Y Ma","year":"2008","unstructured":"Ma Y, Pacan JC, Wang Q, et al. Microencapsulation of bacteriophage felix O1 into chitosan-alginate microspheres for oral delivery. Appl Environ Microbiol. 2008;74:4799\u2013805. https:\/\/doi.org\/10.1128\/AEM.00246-08.","journal-title":"Appl Environ Microbiol"},{"key":"2718_CR133","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.4315\/0362-028x-73.7.1304","volume":"73","author":"K Stanford","year":"2010","unstructured":"Stanford K, McAllister TA, Niu YD, et al. Oral delivery systems for encapsulated bacteriophages targeted at Escherichia coli O157:H7 in feedlot cattle. J Food Prot. 2010;73:1304\u201312. https:\/\/doi.org\/10.4315\/0362-028x-73.7.1304.","journal-title":"J Food Prot"},{"key":"2718_CR134","doi-asserted-by":"publisher","first-page":"5030","DOI":"10.1038\/s41467-020-18614-2","volume":"11","author":"BB Hsu","year":"2020","unstructured":"Hsu BB, Plant IN, Lyon L, et al. In situ reprogramming of gut bacteria by oral delivery. Nat Commun. 2020;11:5030. https:\/\/doi.org\/10.1038\/s41467-020-18614-2.","journal-title":"Nat Commun"},{"key":"2718_CR135","unstructured":"PrePhage\u2014Faecal bacteriophage transfer for enhanced gastrointestinal tract maturation in preterm infants; ClinicalTrials.gov ID NCT05272579; Sponsor Rigshospitalet, Denmark; Information provided by Gustav Riemer Jakobsen, Rigshospitalet, Denmark; Last Update Posted 2024-11-15."}],"updated-by":[{"DOI":"10.1007\/s15010-026-02777-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000}}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-025-02718-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-025-02718-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-025-02718-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T11:44:05Z","timestamp":1782906245000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-025-02718-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":135,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["2718"],"URL":"https:\/\/doi.org\/10.1007\/s15010-025-02718-2","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"assertion":[{"value":"29 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s15010-026-02777-z","URL":"https:\/\/doi.org\/10.1007\/s15010-026-02777-z","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"T.W., S.W. and I.Z. have nothing to disclose. D.Y. declares a collaborative retrospective study with Pfizer and investigator-initiated trial supported by Shionogi (funding to the institution). M.J.G.T.V. has received research grants from MSD, Heel, Roche and Tillotts. She also received consulting fees from GILEAD, Tillotts, Pfizer, Bioaster, GSK, Ecraid, Eumedica, Bactolife and PAION. Furthermore, she received speaker fees from Akademie f\u00fcr Infektionsmedizin, Astra Zeneca, bioMerieux, Biotest, COCS GmbH, DGI, European Society of Neurogastroenterology, Falk Foundation, FomF GmbH, GILEAD, GSK, Helios Kliniken, Hessisches Landessozialgericht, Infektio Forum, Janssen Cilag GmbH, Klinikum Kasseln, Landes\u00e4rztekammer Hessen, LMU Kliniken, MSD, Pfizer, Streamed up, St. Vincent Hospital and Tillotts.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}